ArticleCureus2025
Growth Hormone-Secreting Pituitary Macroadenoma: Diagnosis of Acromegaly in a Young Adult.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acromegaly is a rare endocrinopathy caused by excessive secretion of growth hormone (GH), usually associated with pituitary macroadenomas. Diagnosis is often delayed due to the insidious clinical presentation. We present a 35-year-old male, a baker, previously healthy, who went to the Emergency Department due to episodic, self-limited vertigo. His clinical history revealed chronic night sweats, progressive facial changes, snoring, and breathing pauses. Laboratory tests showed elevated GH and insulin-like growth factor 1 levels (IGF-1), and the MRI confirmed a pituitary macroadenoma. This case illustrates a classic yet underdiagnosed presentation of acromegaly, emphasizing the importance of clinical suspicion even in young and functionally active individuals. Early diagnosis of acromegaly is essential to prevent systemic complications. Recognizing subtle clinical signs can be critical for timely intervention and improving prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.